Insilico Medicine Opens AI Longevity Toolkit Globally

Insilico Medicine launched an open-source AI toolkit on September 17, 2026, to advance global aging research ^[1]. The landmark study appeared as a cover story in the journal Cell ^[2]. This new suite includes three primary components: LongevityBench, Longevity-LLMs, and LongevityClaw ^[3]. These tools aim to help scientists identify new therapeutic targets for age-related diseases ^[1].

The Longevity-LLMs are specifically trained on vast biological datasets to answer complex queries about human aging ^[3]. Meanwhile, LongevityBench provides a standardized framework to evaluate how well AI models predict biological age ^[2]. By making these tools public, Insilico Medicine intends to foster global collaboration in longevity science ^[1][3].